Get the Stockscreener App
1.02
4.08%
0.04
After Hours:
.98
-0.04
-3.92%
Clearmind Medicine Inc Stock (CMND) Forecast
The Clearmind Medicine Inc (CMND) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.6182, representing a -39.39% decrease from the current price of $1.02. The highest analyst price target is $1.0899, and the lowest is $0.1465.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CMND Price Target
Average 1.9803
(+94.15% Upside)
Is Clearmind Medicine Inc (CMND) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.20 | Neutral |
| STOCH(9,6) | 52.85 | Neutral |
| STOCHRSI(14) | 68.27 | Neutral |
| MACD(12,26) | -0.0315 | Buy |
| ADX(14) | 18.25 | Neutral |
| William %R | -48.48 | Neutral |
| CCI(14) | 26.21 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9911
Buy
|
1.0007
Buy
|
| MA20 |
0.9989
Buy
|
1.0167
Buy
|
| MA50 |
1.1118
Sell
|
1.1047
Sell
|
| MA100 |
1.2591
Sell
|
1.2008
Sell
|
| MA200 |
1.3308
Sell
|
1.3004
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, CMND could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on CMND, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 48.2 indicates that CMND is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 52.85 indicates that CMND is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 68.27 indicates that CMND is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.25 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 26.21 indicates that CMND is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CMND price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Clearmind Medicine Inc financial reports and earnings history, Clearmind Medicine Inc (CMND) stock could reach $8.7242 by 2030, $28.93 by 2040 and $23.13 by 2050. See the projected annual prices until 2050 of the Clearmind Medicine Inc stock below:
- Clearmind Medicine Inc (CMND) is expected to reach an average price of $17.50 in 2035, with a high prediction of $18.23 and a low estimate of $17.52. This indicates an $1,616% rise from the last recorded price of $1.02.
- Clearmind Medicine Inc (CMND) stock is projected to chart a bullish course in 2040, with an average price target of $29.00, representing an $2,743% surge from its current level. The forecast ranges from a conservative $28.03 to a sky-high $28.93.
- Our analysts predict Clearmind Medicine Inc (CMND) to jump 1,278% by 2045, soaring from $14.10 to an average price of $14.06, potentially reaching $14.73. While $14.10 is the low estimate, the potential upside is significant.
- Clearmind Medicine Inc (CMND) stock is expected to climb by 2050, reaching an average of $22.67, a $2,123% jump from its current level. However, a wide range of estimates exists, with high and low targets of $23.13 and $23.21, respectively, highlighting the market's uncertainty.
Clearmind Medicine Inc Stock (CMND) Year by Year Forecast
Clearmind Medicine Inc Stock (CMND) Price Forecast for 2025
Clearmind Medicine Inc Stock (CMND) is expected to reach an average price of $2.7362 in 2025, with a high prediction of $5.4305 and a low estimate of $0.0419. This indicates an +168.25% rise from the last recorded price of $1.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $0.7897 | $0.1465 | $1.0899 | -22.57% |
| June, 2025 | $0.2728 | $0.1528 | $1.013 | -73.25% |
| July, 2025 | $0.3042 | $0.0761 | $0.4659 | -70.18% |
| August, 2025 | $1.19 | $0.2824 | $0.4357 | +16.67% |
| September, 2025 | $3.9539 | $2.2135 | $3.8846 | +287.63% |
| October, 2025 | $3.7042 | $3.7412 | $3.7762 | +263.15% |
| November, 2025 | $3.5851 | $3.625 | $3.6546 | +251.48% |
| December, 2025 | $3.4549 | $3.4823 | $3.5187 | +238.71% |
Clearmind Medicine Inc Stock (CMND) Price Forecast for 2026
The predicted value for Clearmind Medicine Inc (CMND) in 2026 is set at an average of $2.3023. Estimates vary from a peak of $4.5604 to a trough of $0.0441, indicating an +125.71% surge from the present price of $1.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.2892 | $3.3062 | $3.3758 | +222.47% |
| February, 2026 | $3.1389 | $3.1501 | $3.2197 | +207.73% |
| March, 2026 | $3.1879 | $3.057 | $3.1539 | +212.54% |
| April, 2026 | $2.9792 | $2.9906 | $3.1184 | +192.08% |
| May, 2026 | $2.7952 | $2.808 | $2.9304 | +174.04% |
| June, 2026 | $0.561 | $0.471 | $4.061 | -45.00% |
| July, 2026 | $1.1463 | $0.0441 | $1.0737 | +12.38% |
| August, 2026 | $0.4901 | $0.7801 | $0.9897 | -51.95% |
| September, 2026 | $0.4974 | $0.6374 | $0.6771 | -51.23% |
| October, 2026 | $0.7513 | $0.7009 | $0.6813 | -26.34% |
| November, 2026 | $0.5552 | $0.5752 | $0.5948 | -45.57% |
| December, 2026 | $5.8204 | $0.4621 | $4.5604 | +470.63% |
Clearmind Medicine Inc Stock (CMND) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Clearmind Medicine Inc (CMND) is $3.2699, with a high forecast of $6.1615 and a low forecast of $0.3782. This indicates an +220.57% increase from the last price of $1.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.1362 | $6.1612 | $6.1615 | +501.59% |
| February, 2027 | $5.806 | $5.8642 | $5.9834 | +469.21% |
| March, 2027 | $5.5439 | $5.6226 | $5.7322 | +443.52% |
| April, 2027 | $5.3345 | $5.3726 | $5.4234 | +422.99% |
| May, 2027 | $5.0945 | $5.1146 | $5.2569 | +399.46% |
| June, 2027 | $4.7365 | $4.7755 | $4.9647 | +364.36% |
| July, 2027 | $4.7267 | $4.7286 | $4.8259 | +363.40% |
| August, 2027 | $4.4752 | $4.4771 | $4.5587 | +338.74% |
| September, 2027 | $0.748 | $4.148 | $4.3802 | -26.66% |
| October, 2027 | $0.9388 | $0.3782 | $2.6916 | -7.96% |
| November, 2027 | $2.6556 | $1.369 | $2.2196 | +160.35% |
| December, 2027 | $1.9906 | $1.9402 | $2.04 | +95.15% |
Clearmind Medicine Inc Stock (CMND) Price Forecast for 2028
In 2028, Clearmind Medicine Inc (CMND) is projected to reach an average price of $4.8558, with a high projection of $8.4384 and a low estimate of $1.2731. This indicates an +376.06% rise from the last price of $1.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.7014 | $1.6812 | $1.5374 | +66.80% |
| February, 2028 | $1.6321 | $1.7221 | $1.632 | +60.01% |
| March, 2028 | $1.3129 | $1.2731 | $1.3527 | +28.72% |
| April, 2028 | $8.8171 | $6.48 | $8.0008 | +764.42% |
| May, 2028 | $8.0894 | $8.1744 | $8.4384 | +693.08% |
| June, 2028 | $7.8031 | $7.8131 | $7.9544 | +665.01% |
| July, 2028 | $7.5158 | $7.5337 | $7.7002 | +636.85% |
| August, 2028 | $7.0855 | $7.1114 | $7.3979 | +594.66% |
| September, 2028 | $6.7532 | $6.7731 | $6.9324 | +562.08% |
| October, 2028 | $6.6014 | $6.494 | $6.6307 | +547.20% |
| November, 2028 | $6.1703 | $6.1745 | $6.4978 | +504.94% |
| December, 2028 | $5.8103 | $5.8183 | $6.0735 | +469.63% |
Clearmind Medicine Inc Stock (CMND) Price Forecast for 2029
The 2029 price forecast for Clearmind Medicine Inc Stock (CMND) is $6.2432 on average, with a high prediction of $10.72 and a low estimate of $1.771. This represents an +512.07% increase from the previous price of $1.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.1779 | $1.771 | $5.7102 | +113.52% |
| February, 2029 | $2.8256 | $2.6018 | $2.2448 | +177.02% |
| March, 2029 | $3.3033 | $3.3733 | $3.4495 | +223.86% |
| April, 2029 | $2.481 | $2.989 | $2.9041 | +143.24% |
| May, 2029 | $2.7157 | $2.7249 | $2.5811 | +166.24% |
| June, 2029 | $2.3384 | $2.3934 | $2.5826 | +129.25% |
| July, 2029 | $8.30 | $2.0842 | $6.8082 | +713.73% |
| August, 2029 | $10.66 | $9.2537 | $10.72 | +945.19% |
| September, 2029 | $10.19 | $10.22 | $10.40 | +898.62% |
| October, 2029 | $9.6818 | $9.7111 | $10.07 | +849.20% |
| November, 2029 | $9.3084 | $9.3358 | $9.4249 | +812.59% |
| December, 2029 | $8.8635 | $8.8805 | $9.1595 | +768.97% |
Clearmind Medicine Inc Stock (CMND) Price Forecast for 2030
Clearmind Medicine Inc Stock (CMND) is expected to reach an average price of $7.9437 in 2030, with a high forecast of $12.99 and a low forecast of $2.8952. This signifies an +678.80% surge from the last price of $1.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $8.3048 | $8.3187 | $8.7242 | +714.20% |
| February, 2030 | $8.0835 | $8.0935 | $8.1698 | +692.50% |
| March, 2030 | $7.6461 | $7.6575 | $7.9451 | +649.62% |
| April, 2030 | $7.1828 | $7.1956 | $7.5275 | +604.20% |
| May, 2030 | $3.941 | $3.1637 | $7.0664 | +286.38% |
| June, 2030 | $4.9057 | $3.9247 | $3.442 | +380.95% |
| July, 2030 | $4.234 | $4.2603 | $4.6793 | +315.10% |
| August, 2030 | $3.6286 | $3.7686 | $4.0176 | +255.75% |
| September, 2030 | $3.6033 | $3.6433 | $3.5333 | +253.26% |
| October, 2030 | $2.9839 | $3.0216 | $3.3769 | +192.53% |
| November, 2030 | $12.79 | $2.8952 | $11.53 | +1,154% |
| December, 2030 | $12.83 | $12.85 | $12.99 | +1,158% |
0.24%
36.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):